, seizure clusters, acute repetitive seizures) which might be distinct from a individual’s standard seizure pattern in clients amongst two and 5 years of age and beating the orphan drug current market exclusivity of the FDA authorized nasal spray product or service of A different company extending to January 2027; concerning the opportunity Gains